Gastroesophageal reflux disease and Barrett’s esophagus

References

• 1 Pandolfino J, Richer J, Ours T. et al . Ambulatory esophageal pH-monitoring using a wireless system.  Am J Gastroenterol. 2003;  98 740-749
• 2 Bruley des Varannes S, Mion F, Ducrotté P. et al . Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo).  Gut. 2005;  54 1682-1686
• 3 Pandolfino J, Zhang Q, Schreiner M. et al . Acid reflux event detection using the Bravo wireless versus the Slimline catheter ph systems: why are the numbers so different?.  Gut. 2005;  54 1687-1692
• 4 Wong W, Bautista J, Dekel R. et al . Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring-a randomized trial.  Aliment Pharmacol Ther. 2005;  21 155-163
• 5 Prakash C, Clouse R. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease.  Clin Gastroenterol Hepatol. 2005;  3 329-334
• 6 Vaezi M, Hicks D, Abelson T. et al . Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association.  Clin Gastroenterol Hepatol. 2003;  1 333-344
• 7 Spechler S. Laryngopharyngeal reflux: A cause of faulty phonation or a faulted phony diagnosis?.  Clin Gastroenterol Hepatol. 2006;  4 431-432
• 8 Eherer A, Habermann W, Hammer H. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study.  Scand J Gastroenterol. 2003;  38 462-467
• 9 Swoger J, Ponsky J, Hicks D. et al . Surgical fundoplication in laryngopharyngeal relux unresponsive to aggressive acid suppression: a controlled study.  Clin Gastroenterol Hepatol. 2006;  4 433-441
• 10 Westcott C, Hopkins M, Bach K. et al . Fundoplication for laryngopharyngeal reflux disease.  J Am Coll Surg. 2004;  199 23-30
• 11 Bittinger M. Messmann H. New endoscopic therapies for gastroesophageal reflux disease [in German].  Z Gastroenterol. 2003;  41 921-928
• 12 Shaheen N. The rise and fall (and rise?) of endoscopic anti-reflux procedures.  Gastroenterology. 2006;  131 952-954
• 13 Rothstein R, Filipi C, Caca K. et al . Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: A randomized sham-controlled trial.  Gastroenterology. 2006;  131 704-712
• 14 Pleskow D, Rothstein R, Lo S. et al . Endoscopic full-thickness plication for the treatment of GERD: 12-month follow-up for the North American open-label trial.  Gastrointest Endosc. 2005;  61 643-649
• 15 Lagergren J. Adenocarcinoma of the oesophagus: What exactly is the size of the problem and who is at risk?.  GUT. 2005;  54 (Suppl I) I1-I5
• 16 Murray L, Watson P, Johnston B. et al . Risk of adenocarcinoma in Barrett’s oesophagus: population based study.  BMJ. 2003;  327 534-535
• 17 Solaymani-Dodaran M, Logan R, West J, Card T. Mortality associated with Barrett’s esophagus and gastroesophageal reflux disease diagnoses - a population-based cohort study.  Am J Gastroenterol. 2005;  100 2616-2621
• 18 Anderson L, Murray L, Murphy S. et al . Mortality in Barrett’s oesophagus: Results from a population based study.  GUT. 2003;  52 1081-1084
• 19 Eckardt V, Kanzler G, Bernhard G. Life expectancy and cancer risk in patients with Barrett’s esophagus: A prospective controlled investigation.  Am J Med. 2001;  111 33-37
• 20 Sampliner R. Updates guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus.  Am J Gastroenterol. 2002;  97 1888-1895
• 21 Kara M, Bergman J. Autofluorescence imaging and narrow-band imaging for the detetction of early neoplasia in patients with Barrett’s esophagus.  Endoscopy. 2006;  38 627-631
• 22 Kara M, Peters F, Rosmolen W. et al . High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett’s esophagus: a prospective crossover study.  Endoscopy. 2005;  37 929-936
• 23 Kara M. Peters F, Fockens P, et al. Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett’s esophagus.  Gastrointest Endosc. 2006;  64 176-185
• 24 Weston A. Can deep freezing join the endoscopic Barrett’s mucosal ablation party? Cautious optimism is warranted.  Gastrointest Endosc. 2005;  62 849-852
• 25 Sampliner R. Endoscopic ablative therapy for Barrett’s esophagus: current status.  Gastrointest Endosc. 2004;  59 66-69
• 26 Johnston M, Eastone J, Horwat J. et al . Cryoablation of Barrett’s esophagus: a pilot study.  Gastrointest Endosc. 2005;  62 842-848
• 27 Overholt B, Lightdale C, Wang K. et al . Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial.  Gastrointest Endosc. 2005;  62 488-498